On 15 April 2024, the Treasury Department’s Office of Investment Security published a Proposed Rule to revise the regulations governing the Committee on Foreign Investment in the United States (CFIUS or the Committee). The Proposed Rule would introduce three key changes to the CFIUS process and mark the most significant update to CFIUS’s authority since the enactment of the Foreign Investment Risk Review Modernization Act of 2018. CFIUS is an interagency body with authority to review foreign... By: K&L Gates LLP ..read more

It’s about cutting through the noise, genuinely engaging with your audience and carving out a distinctive space to showcase your firm and its work online. Stefanie Marrone explains.... By: Stefanie Marrone Consulting ..read more

Millions of additional workers will soon be eligible for overtime pay thanks to the Labor Department’s new salary threshold for certain exempt employees – which raises the rate higher than initially anticipated. Employers will need to act quickly to ensure their pay practices align with this significant change. Specifically, the U.S. Department of Labor (DOL) announced today that the salary threshold for the so-called “white-collar” exemptions will rise from $35K to about $44K on July 1 and will... By: Fisher Phillips ..read more

Title VII of the Civil Rights Act of 1964 (Title VII) and Title IX of the Education Amendments of 1972 (Title IX) both act to prevent discrimination. While Title VII governs employment relationships; Title IX applies in education settings. The question arises as to whether an employee in an education setting must bring their discrimination claim under Title VII and whether they are thereby preempted from bringing a claim under Title IX. While the Supreme Court has ruled that Title IX does not... By: Kohrman Jackson & Krantz LLP ..read more

EPA’s listing of two “forever Chemicals” as CERCLA hazardous substances will re-open sites that companies had thought were closed. And every user of a product that contained them may become responsible for a share of the remediation costs.... By: Snell & Wilmer ..read more

The New York City Department of Consumer and Worker Protection (DCWP) officially debuted its new “Know Your Rights at Work” poster and Workers’ Bill of Rights website.  The poster, which links to the DCWP website via a QR code, aims to serve as a comprehensive resource guide for workers seeking information on City employment rights...... By: Mintz - Employment Viewpoints ..read more

As the historic first (but not last) criminal trial of a former U.S. President was kicking off last week, Mr. Trump commented, “Jury selection is largely luck,” before moving on to his more familiar complaints about the unfairness of the venue, the charges, the judge, and the trial process as a whole. For those who research and work in the area of jury selection, the quip about luck probably yielded a fair amount of head-scratching, especially in light of reports that the Trump team hired jury... By: Holland & Hart - Your Trial Message ..read more

Can an employer’s diversity, equity, and inclusion (DEI) program create liability for the discriminatory harassment of white employees? The U.S. 10th Circuit Court of Appeals (whose rulings apply to employers in Wyoming, Colorado, New Mexico, and Utah) recently warned that the training required by a Colorado state agency included some content that could constitute unwelcome race-based harassment. While the court ultimately rejected the employee’s harassment claim, the opinion serves as a good... By: Holland & Hart - Employers' Lawyers ..read more

Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society). I moderated a panel, “Structuring Your Life Sciences Transaction: Licensing vs. M&A vs. Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics. We were fortunate to have a mix of expert perspectives at the table, representing large pharmaceutical companies, investors,... By: Mintz ..read more

Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO). These fee increases can significantly impact patent applicant behavior, leading prudent applicants to evaluate and adjust their patent protection strategies. Pharmaceutical and biotechnology companies in particular should plan and budget for new and drastically increased fees that impact large and long-lived patent estates.... By: Rothwell, Figg, Ernst & Manbeck, P.C ..read more